Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07751406 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Randomized Trial of a Sun Safety Intervention for Young Adults

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Secondary endpoints: details revised at 3 of 8 entriesv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this randomized controlled trial is to test the efficacy of a dissonance induction intervention compared to a control group on tanning in 278 young adult tanners. The primary outcome will be tanning at 3-months. Secondary outcomes include tanning at 15-months and sunburn and sun protection use 3- and 15-months post-intervention. The main question it aims to answer is whether the intervention reduces tanning and sunburns and increases use of sunscreen among young adults who tan. Participants will be incentivized to develop sun safety and anti-tanning messaging for a social media campaign and to recruit their social ties to engage with those messages. They will then be asked to complete surveys on tanning and sun protection at baseline, 3-, and 15 months. They will also complete monthly surveys to report sunburns. The dissonance induction intervention is based on a highly effective and internationally disseminated eating disorder prevention program that has reached over 3.5 million people around the world.
Trial Details
NCT Number NCT07751406
Lead Sponsor University of Connecticut
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Sunburn
Related terms Sunburn
Enrollment 278 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov